Kelly Skelton

Kelly Skelton is Registry Project Manager for the Australian Particle Therapy Clinical Quality Registry (ASPIRE) at the Australian Bragg Centre for Proton Therapy and Research, where she co-leads Australia’s first radiation oncology specific clinical quality registry. She also serves as Project Manager for the Paediatric Proton Photon Consortium Registry (PPCR), a global collaboration between the Royal Adelaide Hospital, Massachusetts General Hospital and Harvard Medical School, overseeing international data-sharing initiatives focused on paediatric cancer outcomes.

Kelly is a PhD candidate at Adelaide University, where her research focuses on the development and pilot of a national proton therapy survivorship program. Her work aims to generate evidence on long-term outcomes and quality of life for cancer survivors treated with proton versus photon radiation therapy.

With over 20 years’ experience in radiation oncology nursing and research, Kelly has a strong background in clinical registries, data management and multidisciplinary project leadership. She previously worked as a Research Nurse and Data Manager for the Youth Cancer Service SA/NT and as a Clinical Research Associate with the Australasian Oncofertility Registry (FUTuRE Fertility), contributing to research on long-term reproductive health outcomes.

Kelly holds a Master of Cancer Sciences from the University of Melbourne and a postgraduate qualification in adolescent health and wellbeing (oncology stream). She is actively involved in national leadership and advisory groups, including executive roles with the Australian Clinical Trials Alliance (ACTA), Clinical Oncology Society of Australia (COSA), eviQ, and TROG Cancer Research.

She has received multiple awards for her contributions to research and clinical practice, including the SA Health Nursing and Midwifery Excellence Award and the TROG Cancer Research Excellence Award. Kelly is passionate about improving equity of access to advanced cancer treatments and embedding patient-centred outcomes into clinical care and research.